NEUROG1
Neurogenin-1
Also known as: AKA, bHLHa6, Math4C, NEUROD3, ngn1, NGN1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92886
- Gene
- NEUROG1
- Ensembl
- ENSG00000181965
- Chromosome
- 5
- Canonical length
- 237 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nuclear bodies
OverviewNCBI Gene
Enables E-box binding activity and protein homodimerization activity. Involved in several processes, including cochlea morphogenesis; cranial nerve development; and hard palate morphogenesis. Predicted to be located in chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
237 residues, UniProt reviewed canonical sequence.
>Q92886|NEUROG1
1 MPARLETCIS DLDCASSSGS DLSGFLTDEE DCARLQQAAS ASGPPAPARR GAPNISRASE
61 VPGAQDDEQE RRRRRGRTRV RSEALLHSLR RSRRVKANDR ERNRMHNLNA ALDALRSVLP
121 SFPDDTKLTK IETLRFAYNY IWALAETLRL ADQGLPGGGA RERLLPPQCV PCLPGPPSPA
181 SDAESWGSGA AAASPLSDPS SPAASEDFTY RPGDPVFSFP SLPKDLLHTT PCFIPYHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NEUROG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 0.7 nTPM
Expression across tissuesHPA
Tissue
- retina: 0.7 nTPM
- choroid plexus: 0.5 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
- appendix: 0 nTPM
Single-cell type
- oocytes: 51 nCPM
- retinal bipolar cells: 7 nCPM
- breast myoepithelial cells: 0.9 nCPM
- erythrocyte progenitors: 0.5 nCPM
- late spermatids: 0.5 nCPM
- early spermatids: 0.4 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 1.4 nTPM
- choroid plexus: 1.1 nTPM
- midbrain: 0.1 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NEUROG1.
Disease | AllUniProt
Conditions NEUROG1 is implicated in, by any mechanism.
- Cranial dysinnervation disorder, congenital, with absent corneal reflex and developmental delay (CCDDRD) MIM:620469
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 65 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cranial dysinnervation disorder, congenital, with absent corneal reflex and developmental delay
- See cases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.89
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.8
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- auditory behavior
- axon development
- cell fate commitment
- cochlea development
- cochlea morphogenesis
- craniofacial suture morphogenesis
- exit from mitosis
- forebrain development
- genitalia development
- genitalia morphogenesis
- hard palate morphogenesis
- inner ear development
- inner ear morphogenesis
- learned vocalization behavior
- mastication
- negative regulation of relaxation of muscle
- negative regulation of saliva secretion
- nervous system development
- neuromuscular process controlling balance
- peristalsis
- positive regulation of DNA-binding transcription factor activity
- positive regulation of exit from mitosis
- positive regulation of neuron differentiation
- positive regulation of transcription by RNA polymerase II
- regulation of muscle organ development
- regulation of transcription by RNA polymerase II
- sensory organ development
- thorax and anterior abdomen determination
- trigeminal nerve development
- vestibulocochlear nerve formation
Molecular functions
- chromatin binding
- DNA binding
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- E-box binding
- protein homodimerization activity
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NEUROG1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NEUROG1 as an antibody target. Whether an autoantibody or antibody against NEUROG1 could matter depends on whether native NEUROG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NEUROG1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NEUROG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...